<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">6174323</PMID><DateCompleted><Year>1982</Year><Month>05</Month><Day>27</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0091-6765</ISSN><JournalIssue CitedMedium="Print"><Volume>43</Volume><PubDate><Year>1982</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Environmental health perspectives</Title><ISOAbbreviation>Environ Health Perspect</ISOAbbreviation></Journal><ArticleTitle>Use of viral infections in animal models to assess changes in the immune system.</ArticleTitle><Pagination><StartPage>71</StartPage><EndPage>79</EndPage><MedlinePgn>71-9</MedlinePgn></Pagination><Abstract><AbstractText>Viral infections in animal models appear to be ideal systems for determining toxicity to the immune system by environmental substances. Since many viral infections that are utilized in animals produce systemic disease, these models provide an opportunity to evaluate the interaction between virus and components of host resistance. In these infections it is possible to delineate the role of antibody, interferon, cell-mediated immunity, neutrophils and macrophages in response to infection. A change in any of these components responsible for resistance to a particular virus may be correlated with an alteration of mortality an pathogenesis of the viral infection. Three experimental viral infections in mice that are potential candidates for use in determining immunotoxicity are discussed in terms of the response of individual components of resistance to infection and how changes in there components result in alterations of viral pathogenesis. The resistance to encephalomyocarditis virus infection in mice appears to be primarily mediated by antibody and interferon while with herpes simplex virus, infections are mainly controlled through cell-mediated immunity, macrophages, and possible interferon. Cellular immunity also appears to be primarily responsible for resistance to cytomegalovirus infections. Therefore, it is important in the use of these systems for evaluating immunotoxicity to define the pathogenesis of the viral infection and the specific host responses to these infections and to be able to correlate a change in host resistance with an alteration of the viral infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kern</LastName><ForeName>E R</ForeName><Initials>ER</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Environ Health Perspect</MedlineTA><NlmUniqueID>0330411</NlmUniqueID><ISSNLinking>0091-6765</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004785">Environmental Pollutants</NameOfSubstance></Chemical><Chemical><RegistryNumber>9008-11-1</RegistryNumber><NameOfSubstance UI="D007372">Interferons</NameOfSubstance></Chemical><Chemical><RegistryNumber>O84C90HH2L</RegistryNumber><NameOfSubstance UI="D011070">Poly I-C</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003586" MajorTopicYN="N">Cytomegalovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004686" MajorTopicYN="N">Encephalomyocarditis virus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004785" MajorTopicYN="N">Environmental Pollutants</DescriptorName><QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006561" MajorTopicYN="N">Herpes Simplex</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007109" MajorTopicYN="N">Immunity</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007372" MajorTopicYN="N">Interferons</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011070" MajorTopicYN="N">Poly I-C</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="N">Virus Diseases</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1982</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1982</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1982</Year><Month>2</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>1982</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">6174323</ArticleId><ArticleId IdType="pmc">PMC1568886</ArticleId><ArticleId IdType="doi">10.1289/ehp.824371</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Exp Med. 1968 May 1;127(5):1035-52</Citation><ArticleIdList><ArticleId IdType="pubmed">4297630</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother (Bethesda). 1967;7:661-7</Citation><ArticleIdList><ArticleId IdType="pubmed">4299356</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Soc Exp Biol Med. 1969 Nov;132(2):696-8</Citation><ArticleIdList><ArticleId IdType="pubmed">4311209</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1970 May;104(5):1160-5</Citation><ArticleIdList><ArticleId IdType="pubmed">4315461</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1974 Nov;130(5):470-80</Citation><ArticleIdList><ArticleId IdType="pubmed">4371528</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 1975 Jun;7(6):793-800</Citation><ArticleIdList><ArticleId IdType="pubmed">1155920</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Immunol. 1974 Sep;18(1):109-18</Citation><ArticleIdList><ArticleId IdType="pubmed">4377712</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1976 Jan;116(1):35-40</Citation><ArticleIdList><ArticleId IdType="pubmed">173758</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1976 Jun;133 Suppl:A237-44</Citation><ArticleIdList><ArticleId IdType="pubmed">180206</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 1976 Oct;10(4):668-76</Citation><ArticleIdList><ArticleId IdType="pubmed">185951</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1976 Nov 2;144(5):1305-15</Citation><ArticleIdList><ArticleId IdType="pubmed">186554</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1976 Nov 2;144(5):1316-23</Citation><ArticleIdList><ArticleId IdType="pubmed">186555</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Immunol. 1977 Feb;28(2):404-15</Citation><ArticleIdList><ArticleId IdType="pubmed">191199</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1977 Apr;135(4):540-51</Citation><ArticleIdList><ArticleId IdType="pubmed">192804</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1977 May;135(5):763-70</Citation><ArticleIdList><ArticleId IdType="pubmed">192811</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Soc Exp Biol Med. 1977 Apr;154(4):615-20</Citation><ArticleIdList><ArticleId IdType="pubmed">193122</ArticleId></ArticleIdList></Reference><Reference><Citation>Antimicrob Agents Chemother. 1978 Jan;13(1):53-60</Citation><ArticleIdList><ArticleId IdType="pubmed">204250</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1978 Apr;137(4):428-36</Citation><ArticleIdList><ArticleId IdType="pubmed">206632</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1978 Aug;121(2):464-70</Citation><ArticleIdList><ArticleId IdType="pubmed">210231</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1978 Dec;138(6):890-6</Citation><ArticleIdList><ArticleId IdType="pubmed">216752</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1979 Jun;139(6):641-52</Citation><ArticleIdList><ArticleId IdType="pubmed">221597</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Soc Exp Biol Med. 1979 Jul;161(3):341-6</Citation><ArticleIdList><ArticleId IdType="pubmed">223172</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1979 Dec 1;150(6):1549-54</Citation><ArticleIdList><ArticleId IdType="pubmed">229190</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 1964 Sep 1;120:359-74</Citation><ArticleIdList><ArticleId IdType="pubmed">14207057</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>